Results 1 to 10 of about 11,163 (214)

Morphological characteristics of Candida albicans, Candida krusei, Candida guilliermondii, and Candida glabrata biofilms, and response to farnesol [PDF]

Veterinary World, 2021
Background and Aim: Different Candida species isolated in humans and animals have different types of parasite activity. The most pathogenic species is Candida albicans followed by Candida tropicalis.
Nadezhda Sachivkina, Irina Podoprigora, Dmitry Bokov   +2 more
doaj   +5 more sources

Disruption of Protein Mannosylation Affects Candida guilliermondii Cell Wall, Immune Sensing, and Virulence [PDF]

Frontiers in Microbiology, 2016
The fungal cell wall contains glycoproteins that interact with the host immune system. In the prominent pathogenic yeast Candida albicans, Pmr1 acts as a Golgi-resident ion pump that provides cofactors to mannosyltransferases, regulating the synthesis of
María J. Navarro-Arias, Tatiana A. Defosse, Tatiana A. Defosse, Karine Dementhon, Katalin Csonka, Erika Mellado-Mojica, Aline Dias Valério, Roberto J. González-Hernández, Vincent Courdavault, Marc Clastre, Nahúm V. Hernández, Luis Antonio Pérez-García, Dhirendra K. Singh, Csaba Vizler, Attila Gacser, Ricardo S. Almeida, Thierry Noël, Mercedes G. López, Nicolas Papon, Hector M. Mora Montes   +19 more
doaj   +4 more sources

Management of Candida guilliermondii joint infection in a dog. [PDF]

Acta Vet Scand, 2016
Background: Candida spp. are dimorphic fungi in the family Cryptococcaceae. Infections with Candida spp. are usually rare conditions in dogs, but immunocompromised patients have a higher risk for developing invasive candidal infections. Case presentation:
Bufalari A, Maggio C, Moretti G, Crovace A, Crovace A, Stefanetti V, Straubinger RK, Passamonti F.   +7 more
europepmc   +7 more sources

Candida guilliermondii as the aetiology of candidosis Candida guilliermondii como agente de candidose [PDF]

Revista do Instituto de Medicina Tropical de São Paulo, 2006
Candida guilliermondii is one of the components of human microbiota. This yeast has been infrequently associated with human infections, which may be related to its low pathogenicity.
Alessandro Comarú Pasqualotto, Ana Graciela Ventura Antunes, Luiz Carlos Severo   +2 more
doaj   +6 more sources

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati. [PDF]

Antimicrob Agents Chemother, 2018
ABSTRACT A total of 46 clinical isolates of Candida guilliermondii and Candida famata were reidentified genetically, resulting in 27 C. guilliermondii and 12 Candida fermentati strains. The majority of C. guilliermondii
Hirayama T, Miyazaki T, Yamagishi Y, Mikamo H, Ueda T, Nakajima K, Takesue Y, Higashi Y, Yamamoto Y, Kimura M, Araoka H, Taniguchi S, Fukuda Y, Matsuo Y, Furutani A, Yamashita K, Takazono T, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.   +24 more
europepmc   +6 more sources

Experimental therapy with azoles against Candida guilliermondii. [PDF]

Antimicrob Agents Chemother, 2014
ABSTRACT We evaluated the in vitro killing activity of voriconazole (VRC) and posaconazole (PSC) against two clinical isolates of Candida guilliermondii . The two drugs showed fungistatic activity against both isolates and were effective in reducing kidney fungal burden in a ...
Sanchis M, Pastor FJ, Capilla J, Sutton DA, Fothergill AW, Guarro J.   +5 more
europepmc   +4 more sources

Prevalence Rates, Species Distribution and Antifungal Susceptibility of Rare Candida and Related Saccharomycotina Yeasts Causing Bloodstream Infections in 28 Medical Centres. [PDF]

Mycoses
ABSTRACT Background There is a lack of contemporary studies addressing the prevalence rates and antifungal susceptibility of bloodstream infections (BSI) caused by rare yeasts (RY) from the Saccharomycotina subphylum. Objectives This 16‐year multicentre study (2007–2023) aimed to assess the prevalence and antifungal susceptibility of rare yeasts ...
Buonafine CP, Dos Santos AE, Favarello LM, Cognialli RCR, Aquino VR, Mendes AVA, Guimarães T, Sukiennik TCT, Carlesse F, Castro PTOE, Vicente VA, Francisco EC, Colombo AL.   +12 more
europepmc   +2 more sources

A Cross-Sectional Study to Determine <i>Candida</i> spp. Carriage in Libyan Patients With Type 2 Diabetes. [PDF]

Biomed Res Int
The risk for Candida infections in patients with diabetes mellitus (DM) is three times higher than in the general population. Despite a DM prevalence of 15.8% reported in Libya (2024), the laboratory identification and susceptibility testing of fungal infections in patients with DM are not routinely performed.
Esmaio MHM, Abrantes PMDS, Africa CWJ.
europepmc   +2 more sources

Carvacrol Reduces Virulence Traits in Meyerozyma guilliermondii and Candida dubliniensis and Enhances Galleria mellonella Survival During Candidozyma auris Infection [PDF]

Microorganisms
Background: Antifungal resistance among Candida species and related genera, coupled with the lack of new drugs, poses a significant threat to public health.
Andrea Giammarino, Laura Verdolini, Javier Mussin, Giulia Radocchia, Florencia Rojas, Gustavo Giusiano, Letizia Angiolella   +6 more
doaj   +2 more sources

Características fenotípicas útiles para la identificación presuntiva de Candida guilliermondii Useful phenotypic characteristics for presumptive identification of Candida guilliermondii

Revista Argentina de Microbiología, 2007
En el medio CHROMagar Candida, Candida guilliermondii desarrolló una colonia de color rosado-púrpura. En láminas de agar leche-tween 80 al 1%, presentó a las 48 h de cultivo a 28 °C levaduras pequeñas, ovoides y brotantes, de 3 a 5 µm, que no formaron ...
M.V. Pinoni, V. Castán, M.I. Maegli, J. Lorenzo, F. Frizzera, V. Jewtuchowicz, M.T. Mujica   +6 more
doaj   +1 more source